These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 18957965)

  • 1. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.
    Crombez L; Aldrian-Herrada G; Konate K; Nguyen QN; McMaster GK; Brasseur R; Heitz F; Divita G
    Mol Ther; 2009 Jan; 17(1):95-103. PubMed ID: 18957965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery.
    Konate K; Crombez L; Deshayes S; Decaffmeyer M; Thomas A; Brasseur R; Aldrian G; Heitz F; Divita G
    Biochemistry; 2010 Apr; 49(16):3393-402. PubMed ID: 20302329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
    Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
    Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everything you always wanted to know about CADY-mediated siRNA delivery* (* but afraid to ask).
    Konate K; Rydstrom A; Divita G; Deshayes S
    Curr Pharm Des; 2013; 19(16):2869-77. PubMed ID: 23140452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo.
    Crowet JM; Lins L; Deshayes S; Divita G; Morris M; Brasseur R; Thomas A
    Biochim Biophys Acta; 2013 Feb; 1828(2):499-509. PubMed ID: 23000699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles.
    Rydström A; Deshayes S; Konate K; Crombez L; Padari K; Boukhaddaoui H; Aldrian G; Pooga M; Divita G
    PLoS One; 2011; 6(10):e25924. PubMed ID: 21998722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.
    Kurzawa L; Pellerano M; Morris MC
    Biochim Biophys Acta; 2010 Dec; 1798(12):2274-85. PubMed ID: 20188697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
    Furukawa K; Tanaka M; Oba M
    Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and characterization of a new peptide vector for short interfering RNA delivery.
    Chen B; Xu W; Pan R; Chen P
    J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retro-inverso cell-penetrating peptide for siRNA delivery.
    Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
    J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
    Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
    Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
    Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
    Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of amphipathic CPPs with model membranes.
    Deshayes S; Konate K; Aldrian G; Heitz F; Divita G
    Methods Mol Biol; 2011; 683():41-56. PubMed ID: 21053121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake.
    Deshayes S; Konate K; Aldrian G; Crombez L; Heitz F; Divita G
    Biochim Biophys Acta; 2010 Dec; 1798(12):2304-14. PubMed ID: 20541523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histidine-rich cationic amphipathic peptides for plasmid DNA and siRNA delivery.
    Kichler A; Mason AJ; Marquette A; Bechinger B
    Methods Mol Biol; 2013; 948():85-103. PubMed ID: 23070765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of KL4 Peptide Revealed the Importance of Alpha-Helical Structure for Efficient siRNA Delivery.
    Qiu Y; Lo JCK; Kwok KCW; Mason AJ; Lam JKW
    Nucleic Acid Ther; 2021 Jun; 31(3):220-228. PubMed ID: 32352853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of a designed amphipathic cell-penetrating peptide and its effect on solubility, secondary structure, and uptake efficiency.
    Jafari M; Karunaratne DN; Sweeting CM; Chen P
    Biochemistry; 2013 May; 52(20):3428-35. PubMed ID: 23614788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.
    Sharma R; Shivpuri S; Anand A; Kulshreshtha A; Ganguli M
    Mol Pharm; 2013 Jul; 10(7):2588-600. PubMed ID: 23725377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.